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ABACKGROUND Cellular adhesion mediated by cardiac desmo-
somes is a prerequisite for proper electric propagation mediated by
gap junctions in the myocardium. However, the molecular princi-
ples underlying this interdependence are not fully understood.
OBJECTIVE The purpose of this study was to determine potential
causes of right ventricular conduction abnormalities in a patient
with borderline diagnosis of arrhythmogenic right ventricular car-
diomyopathy.
METHODS To assess molecular changes, the patient’s myocardial
tissue was analyzed for altered desmosomal and gap junction
(connexin43) protein levels and localization. In vitro functional
tudies were performed to characterize the consequences of the
esmosomal mutations.
ESULTS Loss of plakoglobin signal was evident at the cell
unctions despite expression of the protein at control levels.
lthough the distribution of connexin43 was not altered, total
rotein levels were reduced and changes in phosphorylation were
bserved. The truncation mutant in desmocollin-2a is deficient in
inding plakoglobin. Moreover, the ability of desmocollin-2a to
irectly interact with connexin43 was abolished by the mutation.
o pathogenic potential of the desmoglein-2 missense change wasSeptember 22, 2010; accepted January 3, 2011.)
1547-5271/$ -see front matter © 2011 Heart Rhythm Society. All rights reservedONCLUSION The observed abnormalities in gap junction pro-
ein expression and phosphorylation, which precede an overt
ardiac phenotype, likely are responsible for slow myocardial
onduction in this patient. At the molecular level, altered
inding properties of the desmocollin-2a mutant may contrib-
te to the changes in connexin43. In particular, the newly
dentified interaction between the desmocollin-2a isoform and
onnexin43 provides novel insights into the molecular link be-
ween desmosomes and gap junctions.
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DSP  desmoplakin; GFP  green fluorescent protein; GST glu-
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Desmosomes provide a rigid link between neighboring
cells, which allows them to withstand mechanical strain. In
these structures, the extracellular portions of desmosomal
cadherins mediate cell adhesion across the cell borders,
while their intracellular modules bind to the plaque proteins
plakoglobin (PG) and plakophilin, which in turn bind des-
moplakin (DSP).1,2 The latter is associated with intermedi-
ate filaments, which establish a mechanical continuum
across cells.3 The importance of this mechanical integrity is
underlined by human disease manifestations. Mutations in
desmosomal genes can result in cardiac disease, including
arrhythmogenic right ventricular cardiomyopathy (ARVC),
cutaneous disorders (palmoplantar keratoderma), and mul-
titissue syndromes (e.g., Naxos disease).4
. doi:10.1016/j.hrthm.2011.01.010
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712 Heart Rhythm, Vol 8, No 5, May 2011In cardiac desmosomes, two desmosomal cadherins
are expressed: desmocollin-2 (DSC2) and desmoglein-2
(DSG2).5 Both have overlapping functions in binding PG
and plakophilin-2 (PKP2), believed to be mediated by a
conserved region in their cytoplasmic portion, the intracel-
lular cadherin segment (ICS).1 Desmocollins are character-
zed by two splice variants (a form and b form) with dif-
erent cytoplasmic portions.6 The DSC2a protein contains
he full ICS domain, whereas this module is significantly
runcated in the DSC2b isoform. The ratio of isoforms
ppears to be controlled in a tissue-specific manner,7 sug-
esting an important regulatory role for tissue integrity.
Desmosomal adhesion is a prerequisite for proper gap
unction formation and maintenance at cell–cell contact
ites.8 Connexin43 (Cx43) is the major ventricular gap junc-
ion protein, which ensures electrical coupling of neighbor-
ng cardiomyocytes.9 In cardiac disease, changes of Cx43
ocalization are often observed.10–13 This phenomenon has
een demonstrated in ARVC patients bearing PKP2 muta-
ions.14,15 The pathologic process of gap junction remodel-
ng is thought to contribute to a high risk for arrhythmias
haracterizing the condition.16 However, the molecular
mechanisms of the impaired link between desmosomal
function and gap junction remodeling are not fully under-
stood.
We present the case of a patient with slow right ventric-
ular (RV) conduction in the presence of a truncation muta-
tion in DSC2 and a missense variant in DSG2. Analysis of
endomyocardial tissue from this patient revealed that mo-
lecular changes in protein expression and phosphorylation
may precede an overt ARVC phenotype. Moreover, our
functional studies on the mutant DSC2 protein shed light on
how the DSC2a isoform may contribute to desmosome and
gap junction interdependence by providing a direct binding
interface for Cx43.
Material and methods
Clinical evaluation
The study was performed in accordance with the 1964
Declaration of Helsinki, and the study protocol was ap-
proved by the local ethics committee. All individuals pro-
vided informed consent. Clinical evaluation included his-
tory, physical examination, 12-lead ECG, signal-averaged
ECG, two-dimensional echocardiography, and 24-hour
ECG monitoring. The diagnosis of ARVC was based on the
recent revision of the Task Force criteria.17
Electrophysiologic study
The patient underwent noncontact mapping study18 of the
V to investigate endocardial activation and the morphol-
gy of noncontact unipolar electrograms in the triangle of
ysplasia. Endocardial isochronal and isopotential maps
ere recorded in sinus rhythm and during steady-state pac-
ng at the RV apex with a cycle length of 400 ms. Total RV
ndocardial activation times and maximum activation gra-
ient were measured as previously described.19,20Histologic and immunohistochemical analysis of
endomyocardial biopsy material
Snap-frozen RV biopsy samples were obtained and ana-
lyzed for protein expression by Western blotting. Formalin-
fixed, paraffin-embedded material was stained with hema-
toxylin and eosin for histologic examination. Unstained
slide-mounted sections were immunostained for N-cadherin
(Sigma, UK), PG (Sigma, UK), and Cx43 (Zymed via
Invitrogen, UK).
Functional studies
Localization studies in HL-1 cells and neonatal rat cardio-
myocytes as well as biochemical binding experiments were
performed to assess the consequences of DSG2 and DSC2
utations. Full experimental details are available in the
nline Supplementary Material.
Results
Identification of a DSC2 mutation in a patient
with RV conduction abnormalities
A 52-year-old woman presented with palpitations and a
family history of sudden cardiac death (Figure S1). Her
resting ECG showed sinus rhythm, PR interval of 190 ms,
QRS duration of 84 ms, and prolongation of the terminal S
wave (55 ms) in lead V1 (Figure S2A). The signal-aver-
aged ECG was negative for late potentials. Noncontact
mapping of the RV demonstrated moderately prolonged
total RV endocardial activation time of 82 ms in sinus
rhythm versus 65 ms recorded in healthy controls.20 Fur-
hermore, the maximum endocardial activation gradient was
nly 0.22 mm/ms, which is 40% of that recorded in healthy
ontrols by our group using this technique (0.51  0.15
mm/ms).21 Fractionated and low-amplitude electrograms
also were identified in the posterior RV wall and postero-
lateral RV outflow tract segments (Figure 1).
Although the patient did not fulfill the diagnostic criteria
for ARVC (Table S1), clear evidence of slow conduction
and fragmented electrograms was seen in the patient’s RV,
and this feature is compatible with a subclinical ARVC
phenotype.22 These sites of electrogram fractionation (Fig-
ure 1B) indicated that local conduction heterogeneities were
present that could promote conduction block and reentry
leading to ventricular arrhythmia. ARVC mutation screen-
ing was performed, and two mutations were identified:
1. A heterozygous deletion was found in exon 16 of DSC2
(c. 2553 delA). This frameshift mutation is predicted to
introduce a premature stop codon at position 855, trun-
cating the last 47 amino acids of the DSC2a isoform
(DSC2 Q851fsX855, Figure 2A).
2. A heterozygous nucleotide change was identified in exon
11 of DSG2 (c. 1550 CT), resulting in an alanine to
valine change at amino acid position 517 (DSG2
A517V). None of the changes was found in 450 controls.
The 18-year-old daughter of the index patient was also
positive for both sequence changes (Figure S1). Clinical
evaluation showed T-wave inversion in leads V1 and V2 on
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713Gehmlich et al DSC2 Mutation Affecting Plakoglobin and Connexin43the ECG (Figure S2B). However, the patient had no other
diagnostic features suggestive of ARVC. Like her mother,
she had a borderline diagnosis of ARVC (Table S1).
Family evaluation revealed that the sudden cardiac death
in the family was unrelated to desmosomal mutations (Fig-
ure S1).
Changes in myocardium in the presence of
desmosomal mutations
Endomyocardial biopsy of the patient showed evidence of
interstitial and replacement fibrosis (Figure 2B). Further-
more, the immunoreactive signal for PG was severely de-
pressed at the cardiac intercalated disks, whereas the adhe-
rens junction protein N-cadherin was clearly present (Figure
2C). These observations are in agreement with molecular
changes occurring in the myocardium of ARVC patients.23
Western blotting for desmosomal components showed
minimal reduction of both DSC2 and DSG2 expression
levels (Figure 3A). Because the truncated DSC2a protein
has electrophoretic mobility similar to that of the DSC2b
form, no quantitative information about isoform ratios
(DSC2a/DSC2b) could be made. Other desmosomal pro-
teins (including PG) and desmin were at control levels. The
total protein content of the gap junction protein Cx43 was
mildly reduced in the patient’s sample (by approximately 20%,
Figure 3C), whereas the band appeared to be migrating differ-
ently (Figure 3A). High-resolution analysis identified two dif-
ferent Cx43 bands for the control sample and one major band
for Cx43 in the patient sample (Figure 3B). This band had an
Figure 1 Right ventricular (RV) conduction abnormalities
n the index patient. Isochronal maps of sinus rhythm are
hown. The maps are orientated in the anterior (A) and
posterior (B) views, respectively. The color scale represents
iming of activation from onset of the QRS complex (red 
early, purple  late). The total RV endocardial activation
time was 82 ms, with latest site of activation in the posterior
RV (site B). The electrograms in this area are fractionated
compared to those in the anterior wall at site A. Similar
fractionated electrograms were also identified in the postero-
lateral RV wall.even slightly higher electrophoretic mobility than the lowerband of the control sample, which is indicative of differences
in Cx43 phosphorylation.24 The gap junction–associated pro-
tein ZO-1 was also found to be slightly reduced.
Immunofluorescence analysis of Cx43 in the endomyo-
cardial biopsy sample showed a normal localization pattern
(Figure 3D). Collectively, analysis of the patient’s myocar-
dial tissue suggested that the desmosomal mutations may
reduce Cx43 protein levels and phosphorylation but not
overall distribution.
Localization studies of DSC2 and DSG2 mutations
Normal localization of the mutant DSC2 and DSG2 proteins
was observed at the desmosomes of the cardiac cell line
HL-1 (Figures 4A and S4C). Moreover, the mutant proteins
were targeted to the intercalated disks of neonatal rat car-
diomyocytes, where they co-localized with the desmosomal
proteins (Figures 4B and S4D). Hence, any pathogenic
action of the mutant proteins would arise from altered pro-
tein function (e.g., binding properties) at the cardiac des-
mosomes. Altered binding properties for the DSG2 A517V
change were not identified (Figure S4).
Functional consequences of the truncated
cytoplasmic domain in DSC2a
The mutation in exon 16 of DSC2 is predicted to have no
direct consequences for the DSC2b splice variant (Figure
5A). In contrast, a large portion of the conserved ICS in the
DSC2a isoform is predicted to be truncated by the mutation.
Because the ICS is thought to mediate binding to other
desmosomal components, binding of the DSC2a mutant to
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714 Heart Rhythm, Vol 8, No 5, May 2011the desmosomal plaque proteins PG and PKP2 was tested.
In GST pulldown experiments, the cytoplasmic portion of
DSC2a wild-type (WT) bound to both PG and PKP2 from
rat heart lysate, whereas DSC2b bound only to PKP2 (Fig-
ure 5B). No binding of the mutant DSC2a protein to PG was
observed, and binding to PKP2 was unaffected. Moreover,
the mutant DSC2a did not bind to a DSP construct (Figure
S5A). Using full-length DSC2a proteins in co-immunopre-
cipitation experiments, the mutant form showed strongly
reduced binding to PG compared with its WT counterpart
(Figure 5C). These experiments suggest that Q851fsX855
may interfere with intradesmosomal protein interactions. In
agreement with the intracellular position of the truncation,
binding to DSG2 (mediated by the extracellular portion)
was preserved (Figure S5B).
The observed changes in Cx43 total protein level and
phosphorylation in the patient’s myocardium (Figure 3)
Figure 2 Histologic and immunohistological changes in the presence of
esmosomal mutations. A: Sequence electropherogram of the heterozy-
gous deletion in exon 16 of DSC2 (c. 2553 delA, top) and of a heterozy-
gous nucleotide change in exon 11 of DSG2 (c. 1550 CT, bottom) in the
index patient (open arrows, left) compared to a control individual (right).
B: Interstitial and replacement fibrosis in a myocardial sample of the
patient (original magnification 40). C: Confocal immunofluorescence
microscopy analysis of nonfailing control tissue and a myocardial sample
from the index patient. The plakoglobin signal is strongly reduced at the
intercalated disks of the index patient, whereas the adherens junction
protein N-cadherin can be abundantly detected at the intercalated disks of
both samples (see also Figure S3). Scale bar at lower left in each panel
represents 10 m.suggested a link between Q851fsX855 and the gap junction kprotein. Accordingly, we examined the possibility of a di-
rect interaction between DSC2a and Cx43. Indeed, the cy-
toplasmic portion of WT DSC2a was found to co-sediment
with Cx43-YFP in GST pulldown assays, but no binding
was observed between DSC2b and Cx43-YFP (Figure 6A).
Moreover, DSC2a WT bound to endogenous Cx43, and
again the mutant DSC2a protein and DSC2b did not bind
(Figure 6B).
The binding site within Cx43 was mapped to its cyto-
plasmic tail (Figure 6C), and only DSC2a WT bound to it,
whereas no binding of either the mutated DSC2a protein or
the DSC2b isoform was detected. Using full-length DSC2a
WT and mutant protein in co-immunoprecipitation experi-
ments, binding to endogenous Cx43 was confirmed for
DSC2a WT, whereas no interaction was detectable between
the mutant DSC2a and Cx43 (Figure 6D).
These results not only point toward a novel direct inter-
action between DSC2a and Cx43 but also indicate that the
abolished interaction between the mutant DSC2a protein
and Cx43 could contribute to the gap junction protein
changes observed in the patient’s myocardium.
Figure 3 Molecular changes in desmosomal and gap junction proteins in
the patient’s myocardium. A: Western blot analysis in the patient (P)
ompared to nonfailing control tissue (NF). Samples were assayed for
esmosomal proteins and connexin43 (Cx43). Blotting for desmin (DES),
arcomeric markers alpha-actinin (ACTN), and myosin heavy chain
MyHC) served as loading controls. B: High-resolution Western blotting of
x43 identified two different bands in the control sample (arrows 1 and 2),
hereas the dominating band in the patient sample migrated even faster
arrow 3) The position of marker proteins (molecular weight in kilodal-
ons) is indicated. C: Reduced total Cx43 protein levels in the patient
ample (Cx43 normalized to desmin, NF set to 1, N  3). D: Confocal
mmunofluorescence microscopy analysis for Cx43 in control and patient
yocardial sample showed normal localization of Cx43 at the intercalated
isks. Scale bar at lower left in each panel represents 10 m. DSC2 
esmocollin-2; DSG2  desmoglein-2; DSP  desmoplakin; PG  pla-
oglobin; PKP2  plakophilin-2.
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Beyond mechanical adhesion, desmosomes have been im-
plicated in signaling processes such as apoptosis, cell mi-
gration, and proliferation.1,2 In particular, a functional link
etween desmosomes and gap junctions has become evident
hrough cardiac disease. In ARVC, mutations in genes cod-
ng for cardiac desmosomal proteins affect gap junction
orphology10 and function,14,15 and this pathologic situa-
tion is thought to contribute to the ventricular arrhythmias
that characterize the disease. In Naxos disease, gap junction
remodeling has been shown to possibly precede fibrofatty
replacement of cardiomyocytes.11
In this study, a patient who presented with delayed RV
endocardial conduction and local fractionation of electro-
grams in the triangle of dysplasia was found to be a carrier
of two desmosomal mutations. Despite the patient’s benign
phenotype, pathologic changes were evident at the molec-
ular level. Immunoreactive signal for PG was remarkably
reduced at the intercalated disks (Figure 2). This feature was
found to characterize remodeling processes occurring in the
myocardium of ARVC patients independent of the under-
Figure 4 Desmocollin-2 (DSC2)
Q851fsX855 mutant is incorporated into
cardiac desmosomes. A: Localization of
DSC2a wild-type (WT) and mutant pro-
teins in transiently transfected HL-1 cells
(first row), counterstained with the cell–
cell contact marker beta-catenin (second
row), nuclei visualized with 4=,6-di-
amidino-2-phenylindole (DAPI; third
row), merged images (fourth row: DSC2
red, beta-catenin green, DAPI blue). Scale
ars represent 10 m. Both WT and mu-
ant DSC2 were primarily found at the
ell–cell contacts. B: Localization of
SC2a WT and mutant proteins at the
ntercalated disks of transfected neonatal
at cardiomyocyte (first row), counter-
tained with DSP (second row), merged
mages (third row: DSC2 red, DSP
green). Scale bar represents 10 m. The
DSC2a mutant protein was incorporated
normally into cardiac desmosomes.lying gene mutation.23 The observation that total PG levelsere unchanged (Figure 3A) supports the hypothesis that
G is redistributed to other cellular pools.25
Moreover, changes in the main cardiac gap junction
protein Cx43 were evident in the patient. Reduced Cx43
protein levels were detected (Figure 3A), and, more impor-
tantly, a shift in electrophoretic mobility was observed (Fig-
ure 3B). In the patient’s sample, faster migrating Cx43 was
more prominent, suggesting a lower proportion of the
highly phosphorylated protein.26 The biologic relevance of
his posttranslational modification at multiple sites in Cx43
s complex, as phosphorylation events are thought to regu-
ate gap junction assembly, disassembly, and channel activ-
ty.24 The slight reduction in gap junction protein ZO-1
indicates that the entire structure might be affected.
A series of in vitro experiments performed provides
insight into the molecular mechanisms that could underlie
the observed changes. Functional studies on the DSG2
A517V change failed to identify any pathogenic potential
(Figure S4). However, we cannot exclude completely that
this conservative change contributes to the phenotype. The
truncated DSC2a Q851fsX855 protein was also found to be
normally incorporated into cardiac desmosomes (Figure 4);
however, it completely abolished binding to PG and DSP,
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716 Heart Rhythm, Vol 8, No 5, May 2011whereas binding to PKP2, which occurred in both DSC2
isoforms, was not affected (Figures 5 and S5). It is likely
that the presence of the mutant DSC2a protein in the cardiac
desmosomes reduces the capacity of these structures to
retain PG, which could contribute to the observed redistri-
bution of PG from junctional pools (Figure 2), as shown for
other ARVC causing DSC2 mutations.27 In particular, nu-
clear translocation of nonjunctional PG may aberrantly
modulate Wnt signaling pathways, driving adipogenesis and
fibrogenesis.25,28 Due to the limited availability of patient
material, we could not stain for other desmosomal proteins
in our myocardial samples. Therefore, the assumption that
PKP2 still is present at the intercalated disks is based solely
on in vitro binding data (Figure 5) and is somewhat spec-
ulative.
The truncation mutation in DSC2 only affects the DSC2a
isoform, whereas the DSC2b splice variant is not affected.
A recent report suggested low expression levels of the
DSC2a isoform in the heart and indicated that truncation
of the last five amino acids of DSC2a by the A897fsX900
Figure 5 DSC2a Q851fsX855 mutant is impaired in binding desmosom
cytoplasmic region (cytopl) of the DSC2a isoform. DSC2a (wild-type [WT]
of the intracellular cadherin segment for each DSC2 protein is given. Aster
M  transmembrane domain. B: Binding of PG and plakophilin-2 (PKP
n GST pulldown assays, together with input control. Glutathione-S-transfe
hereas all DSC2 forms bound PKP2, only DSC2a WT bound also to plak
n co-immunoprecipitation experiments. IP  immunoprecipitated proteinvariant is not sufficient to cause ARVC29 despite reducedbinding to PG.27 In contrast, in our patient with slow
onduction and borderline diagnosis of ARVC, trunca-
ion of a substantial portion of the DSC2a ICS domain by
he Q851fsX855 mutation causes complete loss of bind-
ng to PG and DSP. Moreover, our functional data shed
ew light on the unique cellular functions of the DSC2a
plice isoform in cardiac tissue. Only this isoform (in its
T form), and not its DSC2b counterpart, provides a
irect physical link to Cx43. Whereas the interaction is
ot affected by the A897fsX900 variant, the Q851fsX855
utation abolishes this cellular function of DSC2a (Fig-
re 6B). This may, among many other factors,30,31 con-
tribute to the conduction abnormalities observed in the
patient.
Oxford et al32 reported an interaction between desmosomal
PKP2 and Cx43. However, the binding profiles of WT DSC2a
and DSC2b do not suggest that the DSC2a Cx43 interaction is
mediated by PKP2 (Figure 5). Moreover, PKP2 was not de-
tectable in our immunocomplexes using a Cx43 antibody (Fig-
ure 6D). This discrepancy may be attributable to differences in
oglobin (PG). A: Consequences of the DSC2 Q851fsX855 mutation for
tant) as well as DSC2b are shown schematically. The amino acid sequence
ks Q851. Adapted from Awad et al.5 EC  extracellular cadherin domain;
e cytoplasmic region of DSC2a WT, DSC2a mutant, and DSC2b protein
ST) protein inputs are also shown (marker protein positions on the right).
. C: Impaired binding of DSC2a mutant full-length protein to plakoglobin
control experiment (empty vector).al plak
and mu
isk mar
2) to th
rase (G
oglobinexperimental setups. Additionally, the multimolecular com-
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717Gehmlich et al DSC2 Mutation Affecting Plakoglobin and Connexin43plex analyzed by Oxford et al might also have contained
DSC2a or other bridging molecules. Nevertheless, the obser-
vation that knock-down of PKP2 affects Cx43 expression and
localization as well as cell coupling properties supports our
hypothesis that desmosomal proteins are essential for proper
gap junction function. Down-regulation of PKP2 affected lo-
calization of DSP32 and, most likely, other desmosomal pro-
eins, such as DSC2, as well. Hence, the lack of other desmo-
omal components at the intercalated disks, rather than the loss
f PKP2 itself, could have triggered the redistribution and
own-regulation of Cx43.
Despite the observed molecular changes and evidence of
ignificant reductions in both RV endocardial conduction
ime and activation gradient (a surrogate of conduction
elocity), no ventricular arrhythmia was evident in the pa-
Figure 6 Novel interaction between DSC2a and connexin43 (Cx43),
which is abolished in the mutant DSC2a Q851fsX855 form. A: COS-1
cells coexpressing glutathione-S-transferase (GST) fusion proteins for the
cytoplasmic region of DSC2a (wild-type [WT]) and DSC2b, together with
Cx43 yellow fluorescent protein (YFP) fusion protein were subjected to
GST pulldown assays. Cx43 bound to DSC2a but not to DSC2b. B: DSC2a
T, Q851fsX855 mutant, A897fsX900 variant, and DSC2b cytoplasmic
egion were fused to GST and expressed in COS-1 cells. Binding to
ndogenous Cx43 was observed with DSC2a WT but not for DSC2b. The
utation in DSC2a abolished binding to Cx43, whereas the A897fsX900
ariant was functionally equivalent to WT. Lysate levels indicate that
SC2a predominantly binds the hypophosphorylated form of Cx43. C:
inding of Cx43 cytoplasmic tail (CT) to DSC2a WT, DSC2a mutant, and
SC2b protein in GST pulldown assays. Cx43 cytoplasmic tail was ex-
ressed as a green fluorescent protein (GFP) fusion protein in COS-1 cells
nd assayed for binding to bacterially expressed DSC2 cytoplasmic region
ST fusion proteins (see Figure 5B). Binding was only observed for
SC2a WT and not for the DSC2a mutant or DSC2b. There was no
inding to GFP alone (second row). D: DSC2a mutant protein fails to bind
x43 in co-immunoprecipitation experiments. Transfected full-length
SC2a WT and mutant were assayed for binding to endogenous Cx43,
hich was immunoprecipitated (where indicated,  in AB). Samples
mitting the antibody served as negative controls. Endogenous plakophi-
in-2 (PKP2) was not detectable in immune complexes. The position of the
arker bands is indicated on the right. IP  immunoprecipitated proteins.ient. A similar phenomenon of significantly high “conduc-ion reserve” has been reported in animal models. Mice with
heterozygous deletion of Cx43 in the heart have no overt
henotype, and a reduction of Cx43 protein down to 10% of
ormal levels is required to induce spontaneous arrhyth-
ias.33 These data indicate that reduced Cx43 expression
ontributes to an optimal milieu that facilitates arrhythmo-
enesis in ARVC. However, a specific physiologic trigger
e.g., increased adrenergic tone) promoting ventricular ec-
opy or further modulation of the substrate by inflammatory
rocesses may be required to increase the probability of a
linically important arrhythmic event. These modulations in
he substrate are expected to increase the heterogeneities in
onduction and repolarization kinetics in the ventricle pro-
oting conduction block, reentry, and the generation of
entricular tachycardia and fibrillation.
Analysis of this patient with a subclinical ARVC pheno-
ype provides valuable insight into disease mechanisms.
hanges in gap junction protein Cx43 occur before any
linical manifestation significant enough to fulfill Task
orce criteria for diagnosis but is, nevertheless, detectable
tilizing high-density electrophysiologic mapping of the
ubstrate. Moreover, the newly identified interaction be-
ween DSC2a and Cx43 may contribute to the interdepen-
ence of desmosomal integrity and gap junction function
nd thereby opens avenues for new therapeutic approaches
n ARVC.
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